Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?

DOI record: { "DOI": "10.1007/s40495-021-00257-6", "ISSN": [ "2198-641X" ], "URL": "http://dx.doi.org/10.1007/s40495-021-00257-6", "alternative-id": [ "257" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 1, "value": "16 April 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 2, "value": "22 April 2021" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Ethics Approval and Consent to Participate", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "Not applicable." }, { "group": { "label": "Consent for Publication", "name": "EthicsHeading" }, "name": "Ethics", "order": 3, "value": "Not applicable." }, { "group": { "label": "Conflict of Interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 4, "value": "The authors declare that there is no conflict of interest." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "affiliation": [], "family": "Alkotaji", "given": "Myasar", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0003-2067-4531", "affiliation": [], "authenticated-orcid": false, "family": "Al-Zidan", "given": "Radhwan N.", "sequence": "additional" } ], "container-title": "Current Pharmacology Reports", "container-title-short": "Curr Pharmacol Rep", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2021, 4, 22 ] ], "date-time": "2021-04-22T22:02:52Z", "timestamp": 1619128972000 }, "deposited": { "date-parts": [ [ 2021, 5, 25 ] ], "date-time": "2021-05-25T05:38:08Z", "timestamp": 1621921088000 }, "indexed": { "date-parts": [ [ 2022, 8, 6 ] ], "date-time": "2022-08-06T15:07:18Z", "timestamp": 1659798438689 }, "is-referenced-by-count": 3, "issue": "3", "issued": { "date-parts": [ [ 2021, 4, 22 ] ] }, "journal-issue": { "issue": "3", "published-print": { "date-parts": [ [ 2021, 6 ] ] } }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 4, 22 ] ], "date-time": "2021-04-22T00:00:00Z", "timestamp": 1619049600000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 4, 22 ] ], "date-time": "2021-04-22T00:00:00Z", "timestamp": 1619049600000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s40495-021-00257-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s40495-021-00257-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s40495-021-00257-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "102-106", "prefix": "10.1007", "published": { "date-parts": [ [ 2021, 4, 22 ] ] }, "published-online": { "date-parts": [ [ 2021, 4, 22 ] ] }, "published-print": { "date-parts": [ [ 2021, 6 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1016/S1473-3099(20)30120-1", "author": "E Dong", "doi-asserted-by": "publisher", "first-page": "533", "issue": "5", "journal-title": "Lancet Infect Dis", "key": "257_CR1", "unstructured": "Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.", "volume": "20", "year": "2020" }, { "DOI": "10.1001/jama.2020.2648", "author": "Z Wu", "doi-asserted-by": "publisher", "first-page": "1239", "issue": "13", "journal-title": "JAMA.", "key": "257_CR2", "unstructured": "Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.", "volume": "323", "year": "2020" }, { "key": "257_CR3", "unstructured": "Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Statpearls. 2020." }, { "DOI": "10.1016/j.cmi.2020.07.028", "author": "B Davido", "doi-asserted-by": "publisher", "first-page": "1448", "issue": "11", "journal-title": "Clin Microbiol Infect", "key": "257_CR4", "unstructured": "Davido B, Seang S, Tubiana R, de Truchis P. Post–COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020;26(11):1448–9.", "volume": "26", "year": "2020" }, { "DOI": "10.1001/jama.2020.12603", "author": "A Carfì", "doi-asserted-by": "publisher", "first-page": "603", "issue": "6", "journal-title": "JAMA.", "key": "257_CR5", "unstructured": "Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5.", "volume": "324", "year": "2020" }, { "DOI": "10.1016/S2214-109X(20)30204-7", "author": "Q Liu", "doi-asserted-by": "publisher", "first-page": "e790", "issue": "6", "journal-title": "Lancet Glob Health", "key": "257_CR6", "unstructured": "Liu Q, Luo D, Haase JE, Guo Q, Wang XQ, Liu S, et al. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. Lancet Glob Health. 2020;8(6):e790–e8.", "volume": "8", "year": "2020" }, { "DOI": "10.1097/MD.0000000000022577", "doi-asserted-by": "crossref", "key": "257_CR7", "unstructured": "Liu Y, Wang M, Luo G, Qian X, Wu C, Zhang Y, et al. Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19: a case report. Medicine. 2020;99(42)." }, { "key": "257_CR8", "unstructured": "Barzegar AGM, Rezaei N, Forouzesh M. Valizadeh R. New hope for treatment of respiratory involvement following COVID-19 by bromhexine. J Nephropharmacol. 2021;10(2)." }, { "DOI": "10.1016/j.ijantimicag.2020.106192", "author": "M Alkotaji", "doi-asserted-by": "publisher", "first-page": "106192", "issue": "6", "journal-title": "Int J Antimicrob Agents", "key": "257_CR9", "unstructured": "Alkotaji M. Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2. Int J Antimicrob Agents. 2020;56(6):106192.", "volume": "56", "year": "2020" }, { "DOI": "10.1055/a-1152-3469", "author": "R Kreutz", "doi-asserted-by": "publisher", "first-page": "682", "issue": "10", "journal-title": "Dtsch Med Wochenschr", "key": "257_CR10", "unstructured": "Kreutz R, Algharably EAE-H, Ganten D, Messerli F. Renin-angiotensin-system (RAS) und COVID-19–Zur Verordnung von RAS-Blockern. Dtsch Med Wochenschr (1946). 2020;145(10):682.", "volume": "145", "year": "2020" }, { "DOI": "10.1016/j.jaci.2020.05.033", "author": "K Hosoki", "doi-asserted-by": "publisher", "first-page": "285", "journal-title": "J Allergy Clin Immunol", "key": "257_CR11", "unstructured": "Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective. J Allergy Clin Immunol. 2020;146:285–99.", "volume": "146", "year": "2020" }, { "DOI": "10.20944/preprints202004.0023.v1", "doi-asserted-by": "crossref", "key": "257_CR12", "unstructured": "van de Veerdonk F, Netea MG, Van Deuren M, Van Der Meer JW, De Mast Q, Bruggemann RJ, et al. Kinins and cytokines in COVID-19: a comprehensive pathophysiological approach. 2020." }, { "DOI": "10.1016/j.jaci.2020.08.038", "author": "S Zwaveling", "doi-asserted-by": "publisher", "first-page": "1454", "issue": "6", "journal-title": "J Allergy Clin Immunol", "key": "257_CR13", "unstructured": "Zwaveling S, van Wijk RG, Karim F. Pulmonary edema in COVID-19: explained by bradykinin? J Allergy Clin Immunol. 2020;146(6):1454–5.", "volume": "146", "year": "2020" }, { "DOI": "10.34172/jrip.2020.19", "author": "R Tolouian", "doi-asserted-by": "publisher", "first-page": "e19-e", "issue": "2", "journal-title": "J Ren Inj Prev", "key": "257_CR14", "unstructured": "Tolouian R, Vahed SZ, Ghiyasvand S, Tolouian A, Ardalan M. COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment. J Ren Inj Prev. 2020;9(2):e19-e.", "volume": "9", "year": "2020" }, { "DOI": "10.5152/TurkThoracJ.2018.18014", "author": "İ Yılmaz", "doi-asserted-by": "publisher", "first-page": "36", "issue": "1", "journal-title": "Turk Thorac J", "key": "257_CR15", "unstructured": "Yılmaz İ. Angiotensin-converting enzyme inhibitors induce cough. Turk Thorac J. 2019;20(1):36–42.", "volume": "20", "year": "2019" }, { "DOI": "10.1096/fj.202000967", "author": "JA Roche", "doi-asserted-by": "publisher", "first-page": "7265", "issue": "6", "journal-title": "FASEB J", "key": "257_CR16", "unstructured": "Roche JA, Roche R. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB J. 2020;34(6):7265–9.", "volume": "34", "year": "2020" }, { "DOI": "10.18502/ijaai.v19i(s1.r1).2850", "doi-asserted-by": "crossref", "key": "257_CR17", "unstructured": "Ghahestani S-M, Mahmoudi J, Hajebrahimi S, Khojine ABS, Salehi-Pourmehr H, Sadeghi-Ghyassi F, et al. Bradykinin as a probable aspect in SARS-Cov-2 scenarios: is bradykinin sneaking out of our sight? Iran J Allergy Asthma Immunol. 2020:1–5." }, { "DOI": "10.7554/eLife.57555", "author": "FL van de Veerdonk", "doi-asserted-by": "publisher", "first-page": "e57555", "journal-title": "Elife.", "key": "257_CR18", "unstructured": "van de Veerdonk FL, Netea MG, van Deuren M, van der Meer JW, de Mast Q, Brüggemann RJ, et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020;9:e57555.", "volume": "9", "year": "2020" }, { "DOI": "10.1001/jamanetworkopen.2020.17708", "author": "FL van de Veerdonk", "doi-asserted-by": "publisher", "first-page": "e2017708-e", "issue": "8", "journal-title": "JAMA Netw Open", "key": "257_CR19", "unstructured": "van de Veerdonk FL, Kouijzer IJ, de Nooijer AH, van der Hoeven HG, Maas C, Netea MG, et al. Outcomes associated with use of a kinin B2 receptor antagonist among patients with COVID-19. JAMA Netw Open. 2020;3(8):e2017708-e.", "volume": "3", "year": "2020" }, { "DOI": "10.7554/eLife.59177", "author": "MR Garvin", "doi-asserted-by": "publisher", "journal-title": "Elife.", "key": "257_CR20", "unstructured": "Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9:e59177.", "volume": "9", "year": "2020" }, { "DOI": "10.1038/ki.1992.383", "author": "I Gavras", "doi-asserted-by": "publisher", "first-page": "1020", "issue": "4", "journal-title": "Kidney Int", "key": "257_CR21", "unstructured": "Gavras I. Bradykinin-mediated effects of ACE inhibition. Kidney Int. 1992;42(4):1020–9.", "volume": "42", "year": "1992" }, { "DOI": "10.1161/HYPERTENSIONAHA.118.11070", "author": "D-D Zhang", "doi-asserted-by": "publisher", "first-page": "361", "issue": "2", "journal-title": "Hypertension.", "key": "257_CR22", "unstructured": "Zhang D-D, Gao Z-X, Vio CP, Xiao Y, Wu P, Zhang H, et al. Bradykinin stimulates renal Na+ and K+ excretion by inhibiting the K+ channel (Kir4.1) in the distal convoluted tubule. Hypertension. 2018;72(2):361–9.", "volume": "72", "year": "2018" }, { "DOI": "10.3389/fphys.2018.01500", "author": "J Skogestad", "doi-asserted-by": "publisher", "first-page": "1500", "journal-title": "Front Physiol", "key": "257_CR23", "unstructured": "Skogestad J, Aronsen JM. Hypokalemia-induced arrhythmias and heart failure: new insights and implications for therapy. Front Physiol. 2018;9:1500.", "volume": "9", "year": "2018" }, { "DOI": "10.1177/0004563220922255", "author": "G Lippi", "doi-asserted-by": "publisher", "first-page": "262", "issue": "3", "journal-title": "Ann Clin Biochem", "key": "257_CR24", "unstructured": "Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020;57(3):262–5.", "volume": "57", "year": "2020" }, { "DOI": "10.1001/jama.2020.1585", "author": "D Wang", "doi-asserted-by": "publisher", "first-page": "1061", "issue": "11", "journal-title": "JAMA.", "key": "257_CR25", "unstructured": "Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.", "volume": "323", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "author": "C Huang", "doi-asserted-by": "publisher", "first-page": "497", "issue": "10223", "journal-title": "Lancet.", "key": "257_CR26", "unstructured": "Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.", "volume": "395", "year": "2020" }, { "DOI": "10.1001/jamacardio.2020.1017", "author": "T Guo", "doi-asserted-by": "publisher", "first-page": "811", "issue": "7", "journal-title": "JAMA Cardiol", "key": "257_CR27", "unstructured": "Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–8.", "volume": "5", "year": "2020" }, { "DOI": "10.1136/bmj.m1086", "author": "M Day", "doi-asserted-by": "publisher", "first-page": "m1086", "journal-title": "BMJ.", "key": "257_CR28", "unstructured": "Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368:m1086.", "volume": "368", "year": "2020" }, { "key": "257_CR29", "unstructured": "Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C. Does ibuprofen worsen COVID-19?" }, { "key": "257_CR30", "unstructured": "Updated AF. WHO now doesn’t recommend avoiding ibuprofen for COVID-19 symptoms. ScienceAlert. Retrieved. 2020;19." }, { "author": "LC Esba", "first-page": "1", "journal-title": "Infect Dis Ther", "key": "257_CR31", "unstructured": "Esba LC, Alqahtani RA, Thomas A, Shamas N, Alswaidan L, Mardawi G. Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort study. Infect Dis Ther. 2020;2:1–6.", "volume": "2", "year": "2020" }, { "DOI": "10.1038/nm0796-814", "author": "AJ Fox", "doi-asserted-by": "publisher", "first-page": "814", "issue": "7", "journal-title": "Nat Med", "key": "257_CR32", "unstructured": "Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin–evoked sensitization of airway sensory nerves: a mechanism for ACE–inhibitor cough. Nat Med. 1996;2(7):814–7.", "volume": "2", "year": "1996" }, { "DOI": "10.1186/s12931-019-1060-8", "author": "F Al-Shamlan", "doi-asserted-by": "publisher", "first-page": "1", "issue": "1", "journal-title": "Respir Res", "key": "257_CR33", "unstructured": "Al-Shamlan F, El-Hashim AZ. Bradykinin sensitizes the cough reflex via a B 2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase. Respir Res. 2019;20(1):1–15.", "volume": "20", "year": "2019" }, { "DOI": "10.1159/000196201", "author": "M Cazzola", "doi-asserted-by": "publisher", "first-page": "212", "issue": "4", "journal-title": "Respiration.", "key": "257_CR34", "unstructured": "Cazzola M, Matera MG, Liccardi G, De Prisco F, D’Amato G, Rossi F. Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough. Respiration. 1993;60(4):212–5.", "volume": "60", "year": "1993" }, { "DOI": "10.1016/S0140-6736(95)91151-0", "author": "M Hargreaves", "doi-asserted-by": "publisher", "first-page": "13", "issue": "8941", "journal-title": "Lancet", "key": "257_CR35", "unstructured": "Hargreaves M, Benson M. Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet. 1995;345(8941):13–6.", "volume": "345", "year": "1995" }, { "DOI": "10.1016/S0011-393X(00)88520-3", "author": "R Fogari", "doi-asserted-by": "publisher", "first-page": "121", "issue": "3", "journal-title": "Curr Ther Res", "key": "257_CR36", "unstructured": "Fogari R, Zoppi A, Mugellini A, Preti P, Banderali A, Salvetti A. Effects of amlodipine, nifedipine GITS, and indomethacin on angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked, crossover study. Curr Ther Res. 1999;60(3):121–8.", "volume": "60", "year": "1999" }, { "author": "JR McEWAN", "first-page": "161", "issue": "1", "journal-title": "J Pharmacol Exp Ther", "key": "257_CR37", "unstructured": "McEWAN JR, Choudry NB, Fuller RW. The effect of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Ther. 1990;255(1):161–4.", "volume": "255", "year": "1990" }, { "DOI": "10.1016/S0895-7061(00)00268-5", "author": "A Tenenbaum", "doi-asserted-by": "publisher", "first-page": "776", "issue": "7", "journal-title": "Am J Hypertens", "key": "257_CR38", "unstructured": "Tenenbaum A, Grossman E, Shemesh J, Fisman EZ, Nosrati I, Motro M. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens. 2000;13(7):776–82.", "volume": "13", "year": "2000" }, { "DOI": "10.1161/01.HYP.38.2.166", "author": "S-C Lee", "doi-asserted-by": "publisher", "first-page": "166", "issue": "2", "journal-title": "Hypertension.", "key": "257_CR39", "unstructured": "Lee S-C, Park SW, Kim D-K, Lee SH, Hong KP. Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension. 2001;38(2):166–70.", "volume": "38", "year": "2001" }, { "DOI": "10.1378/chest.129.1_suppl.169S", "author": "PV Dicpinigaitis", "doi-asserted-by": "publisher", "first-page": "169S", "issue": "1", "journal-title": "Chest.", "key": "257_CR40", "unstructured": "Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1):169S–73S.", "volume": "129", "year": "2006" }, { "DOI": "10.1136/bmj.m1185", "doi-asserted-by": "crossref", "key": "257_CR41", "unstructured": "Little P. Non-steroidal anti-inflammatory drugs and covid-19: British Medical Journal Publishing Group; 2020." }, { "DOI": "10.3109/00365519709084587", "author": "A Mäkelä", "doi-asserted-by": "publisher", "first-page": "401", "issue": "5", "journal-title": "Scand J Clin Lab Invest", "key": "257_CR42", "unstructured": "Mäkelä A, Kuusi T, Schröder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest. 1997;57(5):401–7.", "volume": "57", "year": "1997" }, { "DOI": "10.1111/j.1572-0241.2005.41144.x", "author": "H Bahrami", "doi-asserted-by": "publisher", "first-page": "856", "issue": "4", "journal-title": "Am J Gastroenterol", "key": "257_CR43", "unstructured": "Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, et al. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. Am J Gastroenterol. 2005;100(4):856–61.", "volume": "100", "year": "2005" }, { "DOI": "10.1080/003655200750023020", "author": "S Kapiciogğlu", "doi-asserted-by": "publisher", "first-page": "957", "issue": "9", "journal-title": "Scand J Gastroenterol", "key": "257_CR44", "unstructured": "Kapiciogğlu S, Sari M, Kaynar K, Baki A, Özoran Y. The effect of indomethacin on hepatitis B virus replication in chronic healthy carriers. Scand J Gastroenterol. 2000;35(9):957–9.", "volume": "35", "year": "2000" }, { "DOI": "10.1111/cmi.12446", "author": "C Amici", "doi-asserted-by": "publisher", "first-page": "1391", "issue": "9", "journal-title": "Cell Microbiol", "key": "257_CR45", "unstructured": "Amici C, La Frazia S, Brunelli C, Balsamo M, Angelini M, Santoro MG. Inhibition of viral protein translation by indomethacin in vesicular stomatitis virus infection: role of eif2α kinase PKR. Cell Microbiol. 2015;17(9):1391–404.", "volume": "17", "year": "2015" }, { "DOI": "10.1111/head.12769", "author": "S Lucas", "doi-asserted-by": "publisher", "first-page": "436", "issue": "2", "journal-title": "Headache Head Face Pain", "key": "257_CR46", "unstructured": "Lucas S. The pharmacology of indomethacin. Headache Head Face Pain. 2016;56(2):436–46.", "volume": "56", "year": "2016" }, { "DOI": "10.22270/jddt.v10i6.4383", "author": "RN Al-Zidan", "doi-asserted-by": "publisher", "first-page": "219", "issue": "6", "journal-title": "J Drug Deliv Ther", "key": "257_CR47", "unstructured": "Al-Zidan RN. Potential drug-drug and drug-disease interactions of selected experimental therapies used in treating COVID-19 patients. J Drug Deliv Ther. 2020;10(6):219–30.", "volume": "10", "year": "2020" }, { "DOI": "10.3390/ph3072291", "author": "WH Hörl", "doi-asserted-by": "publisher", "first-page": "2291", "issue": "7", "journal-title": "Pharmaceuticals.", "key": "257_CR48", "unstructured": "Hörl WH. Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals. 2010;3(7):2291–321.7.", "volume": "3", "year": "2010" } ], "reference-count": 48, "references-count": 48, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s40495-021-00257-6" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Drug Discovery", "Pharmacology", "Genetics", "Biochemistry" ], "subtitle": [], "title": "Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "7" }